PMID: 7037156Mar 15, 1982Paper

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

Cancer

Abstract

Following curative resection for gastric adenocarcinoma, 142 patients were randomized to receive adjuvant chemotherapy of methyl-CCNU and 5-FU or to be closely followed without chemotherapy. The median patient has been followed for four years. At the present time, there have been 38 recurrences and 40 deaths among the 71 patients in the control arm and 28 recurrences with 29 deaths in the group of patients randomized to chemotherapy. Median survival for control patients is 33 months whereas it is estimated to be in excess of four years for the adjuvant therapy group. A survival advantage appears to be associated with adjuvant treatment, a test for treatment difference being significant (P less than 0.03) after adjustment for important covariates. Survival and disease-free intervals are longer in the chemotherapy arm for patients in all prospective stratification subgroups (proximal and total vs distal subtotal gastrectomy, presence or absence of lymph node metastases, invasion of adjacent organs vs confined to stomach wall and location of tumor within the stomach). A final assessment of this surgical adjuvant approach must await complete results of this trial, as well as of others currently in progress evaluating this same conc...Continue Reading

Citations

Aug 14, 2002·Journal of Surgical Oncology·Vitali SkoropadVasili Zagrebin
Feb 1, 1995·Journal of Surgical Oncology·K KitamuraM Saku
Jan 1, 1993·Seminars in Surgical Oncology·J M JessupG Steele
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·T OkamuraK Sugimachi
Jul 1, 1995·World Journal of Surgery·T Nakajima
Mar 1, 1995·World Journal of Surgery·J S Macdonald, S F Schnall
Jan 1, 1993·Journal of Cancer Research and Clinical Oncology·H J MeyerH Wilke
Aug 1, 1987·World Journal of Surgery·J P Kim
Aug 1, 1987·World Journal of Surgery·P Schlag
May 1, 1984·The Japanese Journal of Surgery·T AkiyoshiH Tsuji
Aug 28, 2003·Current Treatment Options in Oncology·Katsuhiko HiguchiJaffer A Ajani
Nov 18, 2000·Current Gastroenterology Reports·J R Hecht
Apr 9, 2002·Current Oncology Reports·James C Yao, Jaffer A Ajani
Apr 7, 2004·Current Oncology Reports·Alexandria T Phan, Jaffer A Ajani
Apr 16, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·J RingashJ Brierley
May 14, 2005·Critical Reviews in Oncology/hematology·Vincenzo CatalanoEric Van Cutsem
Jan 1, 2000·Chirurgie; mémoires de l'Académie de chirurgie·M Huguier
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P CholletUNKNOWN EORTC Early Clinical Studies Group
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C C Earle, J A Maroun
Oct 17, 1998·Surgical Oncology·J S Lee, H O Douglass
Apr 4, 2003·Critical Reviews in Oncology/hematology·Arnaud D Roth
Nov 12, 2002·Surgical Oncology Clinics of North America·Yuichi KasakuraJaffer Ajani
Nov 3, 1983·The New England Journal of Medicine·J D BoiceJ F Fraumeni
Jul 6, 1995·The New England Journal of Medicine·C S Fuchs, R J Mayer
Oct 8, 1999·Journal of the American College of Nutrition·P R Holt
Oct 11, 2013·Journal of the National Cancer Institute·Koji ObaUNKNOWN GASTRIC group
Feb 2, 2002·American Journal of Clinical Oncology·Dan GreenRicardo Sosa-Sanchez
Mar 17, 1999·Annals of Surgery·J E Niederhuber
Jun 30, 2000·Journal of Clinical Gastroenterology·R De VivoB Daniele
Jul 1, 1987·The American Journal of the Medical Sciences·B L Powell, J B Craig
Sep 6, 2011·The Surgical Clinics of North America·Sameer H Patel, David A Kooby
Dec 1, 1987·International Journal of Radiation Oncology, Biology, Physics·M CaudryH Azaloux
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·W F Regine, M Mohiuddin
Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·J LandryJ Sullinger
Feb 24, 2009·Critical Reviews in Oncology/hematology·Vincenzo CatalanoEric Van Cutsem
Mar 21, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T S LiuY H Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.